Login
Home
About Us
Services
Advances & More News
Medical News
Contact Us
Medical News
From Digestive Disease Week - Higher Adherence to DASH Diet Linked to Stronger Protection Against NAFLD Risk
New findings suggest a higher adherence to the Dietary Approach to Stop Hypertension (DASH) diet had ...
read more
ADA 2022: Glycemic Control After T1D Onset Associated with Long-Term Diabetic Retinopathy Risk
New data show glycemic control obtained during the first year after type 1 diabetes (T1D) onset ...
read more
From ADA 2022 - Sarah Bermudez, PharmD: SGLT2 Inhibitors Underutilized in Heart Failure Care
New findings on the prescribing rates of sodium-glucose cotransporter 2 inhibitors found they are underutilized in ...
read more
Directly from ADAD 2022: High Physical Activity Linked to Poor Glycemia Level in Patients with T1D, Obesity
Among young adults with type 1 diabetes (T1D) and overweight and obesity, new findings suggest higher ...
read more
ADA 2022: Oral Semaglutide Effective Real-World Treatment for Patients with T2D, Uncontrolled A1c
Oral semaglutide is an effective treatment in the real-world for patients with type 2 diabetes (T2D), ...
read more
From ADA 2022 - Roy Taylor, MD: Using Personal Fat Thresholds to Reach Type 2 Diabetes Remission
Body mass index (BMI) may not play as significant a role in defining type 2 diabetes ...
read more
ADA 2022: Semaglutide Significantly Reduces Long-Term Diabetes Risk Among Obesity Patients
Once-weekly 2.4 mg semaglutide is associated with an approximate 60% reduced risk of type 2 diabetes ...
read more
From ARVO 2022 - Pass The Study: An Injected Stem Cell for Patients with Geographic Atrophy
Welcome to Pass the Study, the show where clinical researchers work together to propose a new ...
read more
First
Previous
...
2
3
4
5
6
...
Next
Last